Uniform leader Image Solutions streamlines color and materials management and prepares for global vendor integration Centric Software® is pleased to announce that uniform retailer Image Solutions, has selected Centric PLM™ to drive growth and centralize product development. Centric Software provides the most innovative enterprise solutions to plan, design, develop, source, comply, buy, make, price, allocate, […]

— YUPELRI® (revefenacin) net sales of $66.3 million, recognized by Viatris, increased 22% year-over-year1 — Pivotal Phase 3 CYPRESS study enrollment on track to complete by late summer — Completed sale of TRELEGY ELLIPTA royalty interest to GSK for $225 million — TRELEGY year-to-date sales on track to trigger $50 million milestone in 2025 —

— On track to submit Biologics License Application (BLA) for INO-3107 in 2H25, with the goal of file acceptance by year end — Completed design verification (DV) testing of CELLECTRA® 5PSP device required for BLA submission and requested rolling submission from US Food and Drug Administration (FDA) — Continuing to advance commercial preparations for potential

Terex Corporation (NYSE: TEX) today announced that it has completed a re-pricing of its term loan that is expected to reduce its cash interest costs by approximately $3 million annually. https://mma.prnewswire.com/media/2396979/Logo_2024_Logo.jpg “We are pleased to announce the re-pricing which increases the efficiency of our capital structure,” said Jennifer Kong-Picarello, Terex Senior Vice President and Chief

Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and display processing solutions, today announced financial results for the second quarter ended June 30, 2025. Second Quarter and Recent Highlights — Total revenue increased 16% sequentially, driven by seasonal growth in the home and enterprise market — DreamWorks Animation's The Bad Guys 2 released

Entered into secured credit agreement with Innoviva for $15 million maturing in 2029 Announced positive topline results from the Phase 1b/2a diSArm trial for AP-SA02 Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat

Caris Life Sciences, Inc. (Nasdaq: CAI), a leading, patient-centric, next-generation AI TechBio company, today reported financial results for the quarter ended June 30, 2025. https://mma.prnewswire.com/media/830740/Caris_Life_Sciences_Logo.jpg Second Quarter 2025 Financial Highlights — Reported total revenue of $181.4 million, an increase of 81.3% over the corresponding prior year period. — Completed 50,032 clinical therapy selection cases, an

Rigetti Computing Reports Second Quarter 2025 Financial Results; Announces General Availability of its 36-Qubit Multi-Chip Quantum Computer GlobeNewswire August 12, 2025 BERKELEY, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) — Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its financial results for the second quarter ended June

Fathom achieved 36% year-over-year revenue growth, driven by 25% transaction growth – Fathom Holdings Inc.(Nasdaq: FTHM) (“Fathom” or the “Company”), a national, technology-driven, end-to-end real estate services platform integrating residential brokerage, mortgage, title, and SaaS offerings for brokerages and agents, today reported financial results for the second quarter and first six months ended June 30,

Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced that Driven Tech is No. 1202 on the annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list provides a data-driven snapshot of the most successful companies within the economy's